Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
To study how the body absorbs, distributes, metabolises and eliminates Keppra XR in both children (12 to 16 years old) and adults (18 to 55 years old) with epilepsy.
Age
12 - 55 years
Sex
ALL
Healthy Volunteers
No
Mobile, Alabama, United States
Phoenix, Arizona, United States
Little Rock, Arkansas, United States
Fairfield, Connecticut, United States
Bethesda, Maryland, United States
Dallas, Texas, United States
Start Date
September 1, 2009
Primary Completion Date
March 1, 2010
Completion Date
March 1, 2010
Last Updated
August 6, 2015
25
ACTUAL participants
Keppra XR
DRUG
Lead Sponsor
UCB BIOSCIENCES, Inc.
NCT06700356
NCT02531880
NCT05871372
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions